Feng Zhang

Broad Institute of MIT and Harvard, USA · company speakers →

Feng Zhang is the architect of CRISPR-based genome engineering and next-generation gene modulation platforms. His work is driving next-generation therapeutic modalities that integrate genetic modulation with stem-cell-based neural repair.

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

International Society for Stem Cell Research Annual Meeting

8 July 2026 Montreal, Canada “plenary I: presidential symposium”

ASH Meeting on Hematologic Malignancies

21 August 2026 Chicago, United States “Continuing Conversations With the Speakers on Genome Editing for Transplantation and Cellular Therapies”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →